Nida Khan in TCS Nashik case: Designation disputed, pregnancy cited for bail, police deploy four teams in ongoing manhunt
Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Could intratumoral peptide immunotherapy alter first-line thinking in basal cell carcinoma? Could VP-315 reshape first-line basal cell carcinoma treatment? Read the executive analysis on strategy, competition, and commercial risks. bySoujanya RaviApril 12, 2026